#4623
[68Ga]Ga-DOTA-Exendin-4 PET/CT for the localisation of insulinoma: Results of an international, dual-centre, retrospective, open-label real-world imaging study
Introduction:
Benign insulinomas are the main cause of endogenous hyperinsulinemic hypoglycaemia (EHH) in adults, with surgery as the only cure. Pancreas-preserving procedures are preferred, making precise localisation crucial. Recent studies indicate that GLP-1R imaging, such as [68Ga]Ga-DOTA-exendin-4 (68Ga-Ex4) PET/CT, outperforms conventional imaging in identifying insulinomas.
Conference:
Presenting Author:
Fricke J
Authors:
Fricke J,
Laubner K,
Schildmeijer M,
Menz L,
Christ E,
Keywords:
GLP1-Receptor PET/CT,
Insulinoma,
nesidioblatosis,
endogenous hyperinsulinemic hypoglycaemia,
real-life data,
#1870
Detection of Metastatic Insulinoma with 68Ga-NODAGA-Exendin-4 PET/CT in a Young Child – A Case Report
Introduction:
Malignant insulinomas are extremely rare in children. Localizing metastases of insulinoma is challenging. Imaging modalities like CT and MRI show limited results. Somatostatin-receptor (SSTR) imaging (SRS) performs better. However, a subgroup of malignant insulinoma lack SSRT-2 and can, therefore, not be localized using SRS. We propose that in these cases GLP-1R imaging, using the stable GLP-1 analog exendin, could play an important role.
Conference:
14th Annual ENETSConcerence (2017)
Presenting Author:
Boss M
Authors:
Boss M,
de Herder W,
Hussain K,
Shah P,
Brom M,
Keywords:
Metastatic insulinoma,
GLP-1R,
PET,
exendin,